A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in nine first-line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC) Meeting Abstract


Authors: Goldberg, R. M.; Köhne, C. H.; Seymour, M. T.; de Gramont, A.; Porschen, R.; Saltz, L.; Rougier, P.; Tournigand, C.; Grothey, A.; Sargent, D. J.
Abstract Title: A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in nine first-line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC)
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 166s
Language: English
ACCESSION: WOS:000455043700665
DOI: 10.1200/jco.2007.25.18_suppl.4011
PROVIDER: wos
Notes: Meeting Abstract: 4011 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz